United States - English - NLM (National Library of Medicine)

sa3, llc - lidocaine hydrochloride (unii: v13007z41a) (lidocaine - unii:98pi200987) - lidocaine hydrochloride monohydrate powder intradermal injection system is indicated for use on intact skin to provide topical local analgesia prior to venipuncture or peripheral intravenous cannulation, in children 3–18 years of age. lidocaine hydrochloride monohydrate powder intradermal injection system is indicated for use on intact skin to provide topical local analgesia prior to venipuncture in adults. lidocaine hydrochloride monohydrate is contraindicated in patients with a known history of sensitivity to local anesthetics of the amide type. lidocaine hydrochloride monohydrate powder intradermal injection system was not formally evaluated for effects on reproduction. significant systemic exposure to lidocaine is not expected under recommended conditions of use of lidocaine hydrochloride monohydrate powder intradermal injection system as lidocaine levels were below the limit of detection in human studies. lidocaine has been previously tested for reproductive toxicity in animal studies, however. the follo

United States - English - NLM (National Library of Medicine)

morton grove pharmaceuticals, inc. - lidocaine hydrochloride (unii: v13007z41a) (lidocaine - unii:98pi200987) - lidocaine hydrochloride anhydrous 40 mg in 1 ml - lidocaine hydrochloride topical solution is indicated for the production of topical anesthesia of accessible mucous membranes of the oral and nasal cavities and proximal portions of the digestive tract. lidocaine is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type, or to other components of lidocaine hydrochloride topical solution.

Israel - English - Ministry of Health

lapidot medical import and marketing ltd - lidocaine hydrochloride monohydrate - solution for injection - lidocaine hydrochloride monohydrate 20 mg/ml - lidocaine - local and regional anaesthesia.severe symptomatic ventricular tachycardia or tachy-arrhythmia, if assessed to be life-threatening.

Ireland - English - HPRA (Health Products Regulatory Authority)

laboratoire aguettant - lidocaine hydrochloride monohydrate - solution for injection/infusion - 20 milligram(s)/millilitre - lidocaine

United States - English - NLM (National Library of Medicine)

hospira, inc. - lidocaine hydrochloride (unii: v13007z41a) (lidocaine - unii:98pi200987), dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok) - lidocaine hydrochloride anhydrous 50 mg in 1 ml - 5% lidocaine hydrochloride and 7.5% dextrose injection, usp is indicated for the production of spinal anesthesia when the accepted procedures for this technique as described in standard textbooks are observed. lidocaine is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type. the following conditions preclude the use of spinal anesthesia: - severe hemorrhage, shock or heart block - local infection at the site of proposed puncture - septicemia - known sensitivity to the local anesthetic agent.

United States - English - NLM (National Library of Medicine)

cardinal health - lidocaine hydrochloride (unii: v13007z41a) (lidocaine - unii:98pi200987), epinephrine (unii: ykh834o4bh) (epinephrine - unii:ykh834o4bh) - lidocaine hydrochloride anhydrous 10 mg in 1 ml - lidocaine hydrochloride and epinephrine injection, usp is indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection, by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks, when the accepted procedures for these techniques as described in standard textbooks are observed. lidocaine is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type.

United States - English - NLM (National Library of Medicine)

hospira, inc. - lidocaine hydrochloride (unii: v13007z41a) (lidocaine - unii:98pi200987), epinephrine (unii: ykh834o4bh) (epinephrine - unii:ykh834o4bh) - lidocaine hydrochloride anhydrous 15 mg in 1 ml - lidocaine hydrochloride and epinephrine injection, usp is indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection, by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks, when the accepted procedures for these techniques as described in standard textbooks are observed. lidocaine hcl is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type.

United States - English - NLM (National Library of Medicine)

hospira, inc. - lidocaine hydrochloride (unii: v13007z41a) (lidocaine - unii:98pi200987) - lidocaine hydrochloride anhydrous 10 mg in 1 ml - lidocaine hydrochloride injection, usp is indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks, when the accepted procedures for these techniques as described in standard textbooks are observed. lidocaine hcl is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type.

United States - English - NLM (National Library of Medicine)

general injectables & vaccines, inc - lidocaine hydrochloride (unii: v13007z41a) (lidocaine - unii:98pi200987) - lidocaine hydrochloride anhydrous 10 mg in 1 ml - lidocaine hydrochloride injection administered intravenously or intramuscularly, is specifically indicated in the acute management of ventricular arrhythmias such as those occurring in relation to acute myocardial infarction, or during cardiac manipulation, such as cardiac surgery. lidocaine hydrochloride is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type. lidocaine hydrochloride should not be used in patients with stokes-adams syndrome, wolff-parkinson-white syndrome or with severe degrees of sinoatrial, atrioventricular or intraventricular block in the absence of an artificial pacemaker. although specific studies have not been conducted, lidocaine hcl has been used clinically without evidence of abuse of this drug or of psychological or physical dependence as a result of its use.

United States - English - NLM (National Library of Medicine)

general injectables & vaccine, inc - lidocaine hydrochloride (unii: v13007z41a) (lidocaine - unii:98pi200987) - lidocaine hydrochloride anhydrous 10 mg in 1 ml - lidocaine hydrochloride injection administered intravenously or intramuscularly, is specifically indicated in the acute management of ventricular arrhythmias such as those occurring in relation to acute myocardial infarction, or during cardiac manipulation, such as cardiac surgery. lidocaine hydrochloride is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type. lidocaine hydrochloride should not be used in patients with stokes-adams syndrome, wolff-parkinson-white syndrome or with severe degrees of sinoatrial, atrioventricular or intraventricular block in the absence of an artificial pacemaker. although specific studies have not been conducted, lidocaine hcl has been used clinically without evidence of abuse of this drug or of psychological or physical dependence as a result of its use.